IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
-2.2%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$378M
AUM Growth
+$378M
(+3.3%)
Cap. Flow
+$42.3M
Cap. Flow
% of AUM
11.19%
Top 10 Holdings %
Top 10 Hldgs %
55.17%
Holding
61
New
9
Increased
14
Reduced
9
Closed
5
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$17.8M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$15.3M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$11.5M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$10.2M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.37M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$15.5M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$14.5M |
| 3 |
Halozyme
HALO
|
$11.4M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$11M |
| 5 |
Amgen
AMGN
|
$7.22M |
Sector Composition
| 1 | Healthcare | 96.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $36.2M | 9.57% | 393,000 -51,000 | -11% | -$4.69M |
|
2
Gilead Sciences
GILD
$140B
| $25.1M | 6.63% | 387,784 +39,500 | +11% | +$2.55M |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $20.7M | 5.48% | 43,800 +32,300 | +281% | +$15.3M |
|
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $20.1M | 5.32% | 207,000 +183,000 | +763% | +$17.8M |
|
5
Exelixis
EXEL
$10.1B
| $20M | 5.3% | 886,534 +360,000 | +68% | +$8.13M |
|
6
PTC Therapeutics
PTCT
$3.92B
| $19.3M | 5.11% | 408,000 +75,000 | +23% | +$3.55M |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $18.5M | 4.88% | 133,000 +67,500 | +103% | +$9.37M |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $18.3M | 4.85% | 85,322 -12,000 | -12% | -$2.58M |
|
|
9
Alnylam Pharmaceuticals
ALNY
$58.5B
| $15.4M | 4.06% | 108,800 +72,500 | +200% | +$10.2M |
|
|
10
Ionis Pharmaceuticals
IONS
$6.79B
| $15M | 3.97% | 333,781 +256,000 | +329% | +$11.5M |
|
|
CCXI
11
DELISTED
ChemoCentryx, Inc.
CCXI
| $14.8M | 3.91% | 288,600 +33,000 | +13% | +$1.69M |
|
12
Biogen
BIIB
$19.4B
| $13.6M | 3.59% | 48,500 +15,700 | +48% | +$4.39M |
|
|
BHVN
13
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $12.1M | 3.19% | 176,400 -24,000 | -12% | -$1.64M |
|
|
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11.5M | 3.05% | 67,400 | – | – |
|
|
15
Amgen
AMGN
$155B
| $10.7M | 2.83% | 43,000 -29,000 | -40% | -$7.22M |
|
16
uniQure
QURE
$896M
| $9.49M | 2.51% | 282,034 +254,534 | +926% | +$8.56M |
|
|
XLRN
17
DELISTED
Acceleron Pharma Inc.
XLRN
| $8.2M | 2.17% | 60,500 -10,500 | -15% | -$1.42M |
|
|
TPTX
18
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $7.71M | 2.04% | 81,541 -32,000 | -28% | -$3.03M |
|
19
Incyte
INCY
$16.5B
| $6.34M | 1.68% | 78,000 | – | – |
|
20
Illumina
ILMN
$15.8B
| $6.26M | 1.66% | +16,300 | New | +$6.26M |
|
21
KalVista Pharmaceuticals
KALV
$678M
| $5.49M | 1.45% | 214,533 +37,100 | +21% | +$949K |
|
|
DCPH
22
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.48M | 1.19% | 100,000 +50,000 | +100% | +$2.24M |
|
23
United Therapeutics
UTHR
$13.8B
| $4.45M | 1.18% | +26,600 | New | +$4.45M |
|
|
24
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.17M | 1.1% | 55,156 -192,428 | -78% | -$14.5M |
|
25
Protagonist Therapeutics
PTGX
$3.67B
| $3.94M | 1.04% | 152,000 | – | – |
|